Brief: Belite Bio Announces Proposed Underwritten Public Offering Of American Depositary Shares And Warrants
30/05/2023 21:02
May 30 (Reuters) - Belite Bio Inc BLTE.O :
* BELITE BIO ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING
OF
AMERICAN DEPOSITARY SHARES AND WARRANTS
* BELITE BIO INC - INTENDS TO USE NET PROCEEDS OF OFFERING
FOR
CLINICAL TRIALS AND FURTHER CLINICAL DEVELOPMENT OF TINLAREBANT
* BELITE BIO INC - INTENDS TO USE NET PROCEEDS OF OFFERING
FOR
FUNDING RESEARCH AND DEVELOPMENT OF OTHER PIPELINE PRODUCTS
Source text for Eikon: ID:nGNX9KcWyf
Further company coverage: BLTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Belite Bio
See all newsBrief: Belite Bio Announces Uplisting To The Nasdaq Global Select Market
Brief: Belite Bio Announces Multi-Market Submission Of Marketing Authorization Applications Via The Access Consortium Pathway For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Brief: Belite Bio Announces Submission Of New Drug Application To The Ministry Of Health, Labour, And Welfare In Japan Under The Sakigake Designation System For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Belite Bio, Inc reports results for the quarter ended June 30 - Earnings Summary
Belite Bio Q2 net loss widens on higher expenses